← Leaderboards
Carol A Wallace
Seattle Children'S Hospital
$6,477,417
Attributed
$12,093,578
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2006–10$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$12,093,578 · 10
By mechanism
RC2$6,824,989 · 1
R01$4,134,712 · 1
RC1$994,839 · 1
R21$102,750 · 1
M01$36,288 · 6
Top collaborators
- Norman T. Ilowite4 shared
- Christy Irene Sandborg2 shared
- Laura E Schanberg2 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Shaun William Jackson$9,327,534
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelChildChildhoodAdultClinical TrialsInvestigationChronic Childhood ArthritisQuality Of LifeSafetyPharmaceutical PreparationsPlacebosHealth Care CostsMedicalEventMethodologyDoseSerious Adverse EventRandomizedResourcesMorbidity - Disease RateDouble-Blind MethodPlacebo ControlBlindedDosage
Grant awards (18)
CARRA: Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology$3,037,299
RC2 · FY2010 · AR
Comparative Effectiveness Research in Pediatric Rheumatic Diseases: Leveraging CA$497,190
RC1 · FY2010 · AR · contact PI
CARRA: Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology$3,787,690
RC2 · FY2009 · AR
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$799,711
R01 · FY2009 · AR · contact PI
Comparative Effectiveness Research in Pediatric Rheumatic Diseases: Leveraging CA$497,649
RC1 · FY2009 · AR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$193,417
R01 · FY2009 · AR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$1,106,509
R01 · FY2008 · AR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$20,375
R01 · FY2008 · AR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$1,192,267
R01 · FY2007 · AR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$28,540
R01 · FY2007 · AR · contact PI
THE ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATISIS (APPLE) STUDY$2,434
M01 · FY2007 · RR · contact PI
TOLERABILITY AND PRELIMINARY EFFICACY STUDY OF TWO DOSE LEVELS OF IL-1 TRAP$1,372
M01 · FY2007 · RR · contact PI
TRIPTORELIN FOR OVARY PROTECTION IN CHILDHOOD ONSET LUPUS$229
M01 · FY2007 · RR · contact PI
Early Aggressive Therapy in Juvenile Idiopathic Arthritis$793,893
R01 · FY2006 · AR · contact PI
THE ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATISIS (APPLE) STUDY$19,848
M01 · FY2006 · RR · contact PI
TRIPTORELIN FOR OVARY PROTECTION IN CHILDHOOD ONSET LUPUS$6,617
M01 · FY2006 · RR · contact PI
TOLERABILITY AND PRELIMINARY EFFICACY STUDY OF TWO DOSE LEVELS OF IL-1 TRAP$5,788
M01 · FY2006 · RR · contact PI
Early Aggressive Treatment of Polyarticular JRA$102,750
R21 · FY2001 · AR